72 related articles for article (PubMed ID: 9297107)
1. [Recombinant vaccinia virus expressing Japanese encephalitis virus protein E].
Cheshenko NV; Petrov VS; Protopopova EV; Netesova NA; Konovalova SN; Belavin PA; Loktev VB; Malygin EG
Mol Gen Mikrobiol Virusol; 1997; (3):24-7. PubMed ID: 9297107
[TBL] [Abstract][Full Text] [Related]
2. Expression of envelope glycoprotein (E) of Japanese encephalitis virus by recombinant vaccinia virus.
Haishi S; Imai H; Hirai K; Igarashi A; Kato S
Acta Virol; 1989 Dec; 33(6):497-503. PubMed ID: 2576591
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by the NS3 gene product.
Sato T; Takamura C; Yasuda A; Miyamoto M; Kamogawa K; Yasui K
Virology; 1993 Feb; 192(2):483-90. PubMed ID: 8421896
[TBL] [Abstract][Full Text] [Related]
4. Vero cells infected with vaccinia viruses expressing Japanese encephalitis virus envelope protein induce polykaryocyte formation under neutral conditions.
Konishi E; Yagawa K; Yamanaka A
Jpn J Infect Dis; 2008 Sep; 61(5):410-1. PubMed ID: 18806356
[TBL] [Abstract][Full Text] [Related]
5. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
NAM JH; BANG HS; CHO HW; CHUNG YH
Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
[TBL] [Abstract][Full Text] [Related]
6. Locus of a virus neutralization epitope on the Japanese encephalitis virus envelope protein determined by use of long PCR-based region-specific random mutagenesis.
Morita K; Tadano M; Nakaji S; Kosai K; Mathenge EG; Pandey BD; Hasebe F; Inoue S; Igarashi A
Virology; 2001 Sep; 287(2):417-26. PubMed ID: 11531418
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
8. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
[TBL] [Abstract][Full Text] [Related]
9. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles.
Konishi E; Fujii A; Mason PW
J Virol; 2001 Mar; 75(5):2204-12. PubMed ID: 11160724
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein.
Yaswen LR; Stephens EB; Davenport LC; Hutt-Fletcher LM
Virology; 1993 Aug; 195(2):387-96. PubMed ID: 8393232
[TBL] [Abstract][Full Text] [Related]
12. Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.
Perdiguero B; Blasco R
J Virol; 2006 Sep; 80(17):8763-77. PubMed ID: 16912323
[TBL] [Abstract][Full Text] [Related]
13. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus].
Zheng Q; Li P; Cao R; Hou J; Chen P
Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695
[TBL] [Abstract][Full Text] [Related]
14. Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins.
Kinney RM; Esposito JJ; Johnson BJ; Roehrig JT; Mathews JH; Barrett AD; Trent DW
J Gen Virol; 1988 Dec; 69 ( Pt 12)():3005-13. PubMed ID: 2462013
[TBL] [Abstract][Full Text] [Related]
15. Differential binding efficiency between the envelope protein of Japanese encephalitis virus variants and heparan sulfate on the cell surface.
Liu H; Chiou SS; Chen WJ
J Med Virol; 2004 Apr; 72(4):618-24. PubMed ID: 14981764
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.
Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR
J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432
[TBL] [Abstract][Full Text] [Related]
17. [Expression of human granulocyte-macrophage colony stimulating factor(hGM-CSF) by recombinant vaccinia virus and its effect on immunogenicity].
Liu H; Zhang Z; Yao L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):47-50. PubMed ID: 12515171
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
19. [Generation of recombinant vaccinia virus expressing attachment glycoprotein of Nipah virus].
Wang XJ; Wang OH; Ge JY; Hu S; Bu ZG
Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):644-8. PubMed ID: 17037071
[TBL] [Abstract][Full Text] [Related]
20. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
